Purchase Order 75D30121P10368
Award Date 2/4/21
Potential Completion Date 7/1/21
Potential Value $364K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
South San Francisco, CA 94080, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Twist Bioscience Corporation, a for-profit synthetic biology company based in South San Francisco, California. The $125,565.50 firm fixed price purchase order is for the delivery of SARS COV2 RNA control products to support COVID-19 research and diagnostics efforts. The contract does not have a set-aside designation. Twist Bioscience provides various...
- This is a federal contract award to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California, for the provision of SARS-CoV-2 RNA controls. The contract, valued at $82,080.66, was awarded by the Centers for Disease Control and Prevention (CDC) on July 29, 2020 and has an ultimate completion date of August 29, 2020. The contract is a firm fixed price purchase order and does not have a set-aside designation. Twist Bioscience has been a key provider of...
- The Department of Health and Human Services Centers for Disease Control and Prevention (HHS CDC) awarded a firm fixed price purchase order contract to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California. The $220,065.50 contract is for the provision of SARS COV 2 RNA controls to support COVID-19 research efforts. Twist Bioscience, as a prime contractor, has provided various research products to federal agencies including the NIH, VA, and...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Twist Bioscience Corporation, a for-profit synthetic biology company, to provide TWIST RNA products for the FLUSC2 MULTIPLE program. The $51,160.00 contract does not have a set-aside designation and is scheduled for completion by April 30, 2024. Twist Bioscience, a manufacturer of goods, has previously received numerous federal contracts to supply synthetic...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $157,390 firm fixed price purchase order contract to Twist Bioscience Corporation for the delivery of "LAP SUPPLIES." This contract, which has a completion date of September 14, 2025, does not include a set-aside designation. Twist Bioscience is a synthetic biology company that specializes in the manufacture of high-quality synthetic DNA products and services. Through this contract, Twist Bioscience will likely provide...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California. The $97,588 contract is for the provision of COVID-19 DNA constructs, which likely support genomics research, disease surveillance, and public health initiatives. This contract does not have a set-aside designation. Twist...
- The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $14,406.58 firm fixed price purchase order to Twist Bioscience Corporation of South San Francisco, California. Under the contract, Twist Bioscience will provide clonal genes in support of HHS-CDC's efforts to advance public health. As a leading synthetic biology company, Twist Bioscience will leverage its gene synthesis platform to deliver the requested products for use in HHS-CDC's...
- This is a firm fixed price purchase order contract awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Twist Bioscience Corporation, a for-profit synthetic biology company based in South San Francisco, California. The contract is for the provision of biological and reagent materials, with a ceiling value of $12,206.25 and a period of performance through September 4, 2025. There is no set-aside designation for this...
- This federal contract award to Twist Bioscience Corporation, a synthetic biology company in South San Francisco, CA, is for the delivery of COVID-19 DNA constructs. The $29,671.85 firm fixed price purchase order was awarded on June 4, 2020 by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH). The contract does not have a set-aside designation. Through this award, as well as previous contracts and grants, Twist...
- This is a $14,031.25 firm fixed price purchase order awarded by the National Human Genome Research Institute (NHGRI) to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California. The contract is for Twist Bioscience to provide a custom capture panel to support a new blood-based cancer diagnostic that will detect human herpesvirus 8 (HHV8) in the plasma of HIV patients. The award has an ultimate completion date of October 31, 2024 and was made on August...